CAMBRIDGE, MA / ACCESS Newswire / August 1, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the UK Court of Appeal ...

That kind of shot was first used during the Covid-19 pandemic, but the health secretary has been sharply critical of the ...

Growth in the Lipid Nanoparticles (LNPs) market is driven by increasing demand for mRNA-based therapeutics and advances in ...

The Allan Labor Government has welcomed a new BioNTech clinical trial platform that will provide cancer patients with easier access to the next ...

Health Secretary Robert F. Kennedy Jr. has canceled nearly $500 million of grants and contracts for developing mRNA vaccines, ...

The company posted strong second-quarter results and reaffirmed its guidance for 2025. Enbridge posted EBITDA of C$4.6 ...

Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...

Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...

The Mpox outbreak has renewed interest in Kenya from various foreign vaccine suppliers. One of the few WHO-approved Mpox ...

The most special thing about a vaccine is that it not only controls or reduces the disease, but taking it does not cause the ...

This marks Health Secretary Kennedy Jr's latest effort to weave vaccine scepticism into US policy. Read more at ...

US Health and Human Services is “winding down” its mRNA vaccine development and will instead fund other vaccine platforms ...